Long-term efficacy and safety of ustekinumab in patients with moderate to severe psoriasis through 5 years of follow-up: results from the PHOENIX 1 long-term extension

被引：0
|
作者：
Kimball, A. B. [1 ,2 ]
Papp, K. A. [3 ]
Wasfi, Y. [4 ]
Chan, D. [4 ]
Bissonnette, R. [5 ]
Sofen, H. [6 ]
Yeilding, N. [4 ]
Li, S. [4 ]
Szapary, P. O. [4 ]
Gordon, K. B. [7 ,8 ]
机构：
[1] Harvard Univ, Sch Med, Boston, MA USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Prob Med Res, Waterloo, ON, Canada
[4] Janssen Res & Dev LLC, Spring House, PA USA
[5] Innovaderm Res Inc, Montreal, PQ, Canada
[6] Dermatol Res Associates, Los Angeles, CA USA
[7] N Shore Univ Hlth Syst, Chicago, IL USA
[8] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2012年 / 167卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：63 / 64
页数：2
相关论文
共 50 条
  • [31] Bimekizumab efficacy and safety through 3 years in patients with moderate to severe plaque psoriasis: Long-term results from the BE SURE trial and BE BRIGHT open-label extension
    Sinclair, Rodney
    Thaci, Diamant
    Vender, Ronald
    de Rie, Menno
    Conrad, Curdin
    Soung, Jennifer
    Strober, Bruce
    Wang, Maggie
    Cross, Nancy
    Deherder, Delphine
    Gomez, Natalie Nunez
    Gottlieb, Alice B.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 18 - 18
  • [32] Efficacy and Safety of Ustekinumab for Crohn's Disease Through 5 Years: Final Results From the IM-UNITI Long-Term Extension
    Sandborn, William J.
    Rutgeerts, Paul
    Lynch, John
    Rebuck, Rory
    Wang, Yuhua
    Zou, Bin
    Gasink, Christopher
    Adedokun, Omoniyi
    Sands, Bruce E.
    Hanauer, Stephen
    Targan, Stephan
    Ghosh, Subrata
    de Villiers, Willem J. S.
    Colombel, Jean-Frederic
    Feagan, Brian G.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S323 - S324
  • [33] Long-term safety and efficacy of risankizumab for the treatment of moderate- to-severe plaque psoriasis: Interim analysis of the LIMMitless open-label extension trial up to 5 years of follow-up
    Papp, Kim A.
    Blauvelt, Andrew
    Puig, Lluis
    Ohtsuki, Mamitaro
    Beissert, Stefan
    Gooderham, Melinda
    Amin, Ahmad Z.
    Liu, Jie
    Wu, Tianshuang
    Azam, Tofial
    Stakias, Vassilis
    Espaillat, Ramon
    Sinvhal, Ranjeeta
    Soliman, Ahmed M.
    Pang, Yinuo
    Chen, Michael M.
    Lebwohl, Mark G.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (06) : 1149 - 1158
  • [34] Long-term outcomes of ustekinumab in patients with moderate-to-severe psoriasis in a university hospital
    Ossorio-Garcia, Lidia
    Collantes-Rodriguez, Cristina
    Jimenez-Gallo, David
    Linares-Barrios, Mario
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB179 - AB179
  • [35] Efficacy of Ustekinumab for Ulcerative Colitis in Patients Through 3 Years: UNIFI Long-term Extension
    Abreu, Maria T.
    Rowbotham, David S.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Scherl, Ellen
    Leong, Rupert
    Arasaradnam, Ramesh
    Afif, Waqqas
    Peyrin-Biroulet, Laurent
    Sands, Bruce E.
    Marano, Colleen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S315 - S315
  • [36] Levetiracetam:: a long-term follow-up study of efficacy and safety
    Bauer, J.
    Ben-Menachem, E.
    Kraemer, G.
    Fryze, W.
    Da Silva, S.
    Kasteleijn-Nolst Trenite, D. G. A.
    ACTA NEUROLOGICA SCANDINAVICA, 2006, 114 (03): : 169 - 176
  • [37] Bimekizumab Efficacy and Safety Through 4 Years in Moderate to Severe Plaque Psoriasis: Long-Term Results from a Phase 3 Study and Open-Label Extension
    Thaci, Diamant
    Puig, Luis
    Merola, Joseph F.
    Jullien, Denis
    Costanzo, Antonio
    Wang, Maggie
    Deherder, Delphine
    Lopez Pinto, Jose M.
    Lebwohl, Mark
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4733 - 4735
  • [38] Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension
    Abreu, Maria T.
    Rowbotham, David S.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Tikhonov, Ilia
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Scherl, Ellen J.
    Leong, Rupert W.
    Arasaradnam, Ramesh P.
    Afif, Waqqas
    Peyrin-Biroulet, Laurent
    Sands, Bruce E.
    Marano, Colleen
    JOURNAL OF CROHNS & COLITIS, 2022, 16 (08): : 1222 - 1234
  • [39] Long-term safety and tolerability of apremilast in patients with moderate to severe psoriasis: Results from the LIBERATE study
    Crowley, Jeffrey
    Langley, Richard
    Zhang, Zuoshun
    Goncalves, Joana
    Paris, Maria
    Reich, Kristian
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB259 - AB259
  • [40] EFFICACY AND SAFETY OF INFLIXIMAB IN PATIENTS WITH ACTIVE SPONDYLOARTHRITIS: RESULTS OF A LONG-TERM FOLLOW-UP STUDY
    Devinck, M.
    Carron, P.
    Mielants, H.
    van den Bosch, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : 623 - 623
12345